Covid 19 Guidance
FOR SECONDARY CARE ONLY
Adoption of NHS England’s Interim Clinical Commissioning Policy: Thrombopoietin receptor agonists [Romiplostim and Eltrombopag] as first line therapy for new or relapsed immune thrombocytopenia in adults during the COVID-19 pandemic and accompanying documents:
Early use of TPOs in adult ITP patients Kent&Medway CCG Aug 2021
Covid19 - Guidance on management of ITP Kent&Medway CCG Aug 2021
C1066i Interim Clinical Commissioning Policy TPO RA for- ITP Kent&Medway CCG Aug 2021
- First Line Choice
- On Formulary
- Specialist Initiation Only
- Hospital Only
- KMPT Initiation Only